查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1842016

美國動靜脈瘻管裝置市場：市場規模、佔有率、趨勢分析（按類型和最終用途分類）、細分市場預測（2025-2033 年）

U.S. Arteriovenous Fistula Devices Market Size, Share & Trends Analysis Report By Type, By End-use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格

美國動靜脈瘻管器械市場摘要

據估計，2024 年美國動靜脈瘻管裝置市值為 1.11 億美元，預計到 2033 年將達到 1.2 億美元，2025 年至 2033 年的複合年成長率為 0.9%。

這一成長是由多種因素驅動的，包括末期腎功能衰竭(ESRD) 的患病率不斷上升以及由此導致的需要血液透析機的患者人數增加。

先進的醫療基礎設施、糖尿病和高血壓的高發病率以及美國廣泛的意識提升提升預計將推動市場成長。根據美國疾病管制與預防中心 (CDC) 2023 年的估計，美國約有 14% 的成年人患有慢性腎臟病(CKD)。此外，根據美國腎臟基金會的報告，目前約有 81.5 萬美國患有腎衰竭，其中約 55.5 萬人正在接受透析治療。

腎臟捐贈者嚴重短缺導致透析依賴性增加，凸顯了動靜脈瘻管（AVF）裝置在末期腎臟病（ESRD）治療中的關鍵作用。腎臟疾病的增加也推動了對更先進、更具創新性的AVF解決方案的需求。與其他存取類型相比，AVF具有耐用性強、感染率低、併發症風險低等優點，因此是長期血管通路的首選。這些因素正在推動AVF在美國的快速發展。

動靜脈移植（AVG）和中央靜脈導管（CVC）是血液血液透析機中除動靜脈瘻管（AVF）以外的兩種主要血管通路方式。通路方式的選擇具有重要的臨床和經濟意義，並直接影響市場動態。 AVF因其感染率低、使用壽命長而被認為是黃金標準，但其成熟時間長、初始失敗率高，因此需要尋找替代方案。

目錄

第1章 分析方法和範圍

第2章執行摘要

第3章美國動靜脈瘻管器械市場：促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場
    • 附隨市場
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 美國動靜脈瘻管器械市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL分析
    • 法律規範

第4章美國動靜脈瘻管裝置市場：按類型分類的估算與趨勢分析

  • 細分儀表板
  • 美國動靜脈瘻管裝置市場：按類型分類的差異分析
  • 美國動靜脈瘻管裝置市場規模及趨勢分析（按類型分類）（2021-2033 年）
    • AVF 創建設備
    • AVF監測設備
    • AVF維修裝置

第5章美國動靜脈瘻管設備市場：依最終用途分類的估算與趨勢分析

  • 細分儀表板
  • 美國動靜脈瘻管器械市場：依最終用途分類的差異分析
  • 美國動靜脈瘻管裝置市場規模及趨勢分析（依最終用途分類）（2021-2033 年）
    • 醫院
    • 門診手術中心
    • 透析中心

第6章 競爭情勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • 主要企業泥炭地分佈圖分析（2024 年）
  • 公司簡介
    • Medtronic
    • BD
    • Teleflex Incorporated
    • Fresenius Medical Care
    • B. Braun Medical Inc.
    • Polymed
    • Laminate Medical Technologies Ltd.
    • Cook Group
    • Smiths Group plc
Product Code: GVR-4-68040-758-5

U.S. Arteriovenous Fistula Devices Market Summary

The U.S. arteriovenous fistula devices market size was estimated at USD 111.0 million in 2024 and is projected to reach USD 120.0 million by 2033, growing at a CAGR of 0.9% from 2025 to 2033. The growth is attributed to several factors, including the increasing prevalence rate of End-stage Renal Disease (ESRD) and the resulting rise in the number of patients requiring hemodialysis.

The advanced healthcare infrastructure, a high incidence of diabetes & hypertension, and widespread awareness initiatives in the country are expected to drive the market growth. According to 2023 estimates by the Centers for Disease Control and Prevention (CDC), approximately 14% of adults in the U.S. are affected by chronic kidney disease (CKD). Furthermore, the American Kidney Fund reports that approximately 815,000 Americans are currently living with kidney failure, with nearly 555,000 of them undergoing dialysis, highlighting the widespread need for effective treatment solutions.

Due to the critical shortage of kidney donors, the increasing dependence on dialysis underscores the essential role of AVF devices in managing ESRD. The escalating rate of kidney disease is also driving the demand for more advanced and innovative AVF solutions. AV fistulas are preferred for long-term vascular access because of their durability, lower infection rates, and reduced complication risk compared to other access types. These factors are propelling the growth of AVF devices in the U.S.

Two other types of vascular access for hemodialysis, arteriovenous graft (AVG) and central venous catheter (CVC), are the primary substitutes for an arteriovenous fistula. The choice of access has significant clinical and economic implications, directly impacting market dynamics. While AVFs are considered the gold standard due to lower infection rates and better longevity, their long maturation time and high primary failure rate make substitutes necessary.

U.S. Arteriovenous Fistula Devices Market Report Segmentation

This report forecasts revenue growth at a country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. arteriovenous fistula devices market report based on type and end-use.

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • AVF Creation Devices
    • Surgical Instruments
    • Vascular Grafts
    • Angioplasty Balloons
    • Others
  • AVF Monitoring Devices
    • Doppler Ultrasound
    • Pressure Monitoring Systems
    • Others
  • AVF Maintenance Devices
    • Central Venous Catheters
    • Stents
    • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Ambulatory Surgical Centers
  • Dialysis Centers

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
    • 1.4.5. Details of primary research
  • 1.5. Information/Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type Outlook
    • 2.2.2. End Use Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Arteriovenous Fistula Devices Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market
    • 3.1.2. Ancillary Market
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. U.S. Arteriovenous Fistula Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitution
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
    • 3.3.3. Regulatory Framework

Chapter 4. U.S. Arteriovenous Fistula Devices Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Arteriovenous Fistula Devices Market: Type Movement Analysis
  • 4.3. U.S. Arteriovenous Fistula Devices Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
    • 4.3.1. AVF Creation Devices
      • 4.3.1.1. AVF Creation Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.2. Surgical Instruments
        • 4.3.1.2.1. Surgical Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.3. Vascular Grafts
        • 4.3.1.3.1. Vascular Grafts Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.4. Angioplasty Balloons
        • 4.3.1.4.1. Angioplasty Balloons Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.5. Others
        • 4.3.1.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2. AVF Monitoring Devices
      • 4.3.2.1. AVF Monitoring Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.2. Doppler Ultrasound
        • 4.3.2.2.1. Doppler Ultrasound Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.3. Pressure Monitoring Systems
        • 4.3.2.3.1. Pressure Monitoring Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.4. Others
        • 4.3.2.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.3. AVF Maintenance Devices
      • 4.3.3.1. AVF Maintenance Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.2. Central Venous Catheters
        • 4.3.3.2.1. Central Venous Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.3. Stents
        • 4.3.3.3.1. Stents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.4. Others
        • 4.3.3.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Arteriovenous Fistula Devices Market: By End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Arteriovenous Fistula Devices Market: By End Use Movement Analysis
  • 5.3. U.S. Arteriovenous Fistula Devices Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
    • 5.3.1. Hospitals
      • 5.3.1.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.2. Ambulatory Surgical Centers
      • 5.3.2.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.3. Dialysis Centers
      • 5.3.3.1. Dialysis Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. Key company Heat Map Analysis, 2024
  • 6.4. Company Profiles
    • 6.4.1. Medtronic
      • 6.4.1.1. Company Overview
      • 6.4.1.2. Financial Performance
      • 6.4.1.3. Product Benchmarking
      • 6.4.1.4. Strategic Initiatives
    • 6.4.2. BD
      • 6.4.2.1. Company Overview
      • 6.4.2.2. Financial Performance
      • 6.4.2.3. Product Benchmarking
      • 6.4.2.4. Strategic Initiatives
    • 6.4.3. Teleflex Incorporated
      • 6.4.3.1. Company Overview
      • 6.4.3.2. Financial Performance
      • 6.4.3.3. Product Benchmarking
      • 6.4.3.4. Strategic Initiatives
    • 6.4.4. Fresenius Medical Care
      • 6.4.4.1. Company Overview
      • 6.4.4.2. Financial Performance
      • 6.4.4.3. Product Benchmarking
      • 6.4.4.4. Strategic Initiatives
    • 6.4.5. B. Braun Medical Inc.
      • 6.4.5.1. Company Overview
      • 6.4.5.2. Financial Performance
      • 6.4.5.3. Product Benchmarking
      • 6.4.5.4. Strategic Initiatives
    • 6.4.6. Polymed
      • 6.4.6.1. Company Overview
      • 6.4.6.2. Financial Performance
      • 6.4.6.3. Product Benchmarking
      • 6.4.6.4. Strategic Initiatives
    • 6.4.7. Laminate Medical Technologies Ltd.
      • 6.4.7.1. Company Overview
      • 6.4.7.2. Financial Performance
      • 6.4.7.3. Product Benchmarking
      • 6.4.7.4. Strategic Initiatives
    • 6.4.8. Cook Group
      • 6.4.8.1. Company Overview
      • 6.4.8.2. Financial Performance
      • 6.4.8.3. Product Benchmarking
      • 6.4.8.4. Strategic Initiatives
    • 6.4.9. Smiths Group plc
      • 6.4.9.1. Company Overview
      • 6.4.9.2. Financial Performance
      • 6.4.9.3. Product Benchmarking
      • 6.4.9.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. arteriovenous fistula devices market, by type, 2021 - 2033 (USD Million)
  • Table 3 U.S. arteriovenous fistula devices market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 U.S. arteriovenous fistula devices market revenue, 2021 - 2033 (USD Million)
  • Fig. 10 U.S. arteriovenous fistula devices market snapshot
  • Fig. 11 U.S. arteriovenous fistula devices market driver impact
  • Fig. 12 U.S. arteriovenous fistula devices market restraint impact
  • Fig. 13 U.S. arteriovenous fistula devices type key takeaways (USD Million)
  • Fig. 14 U.S. arteriovenous fistula devices market: type movement analysis
  • Fig. 15 AVF creation devices market, 2021 - 2033 (USD Million)
  • Fig. 16 AVF monitoring devices market, 2021 - 2033 (USD Million)
  • Fig. 17 AVF maintenance devices market, 2021 - 2033 (USD Million)
  • Fig. 18 U.S. arteriovenous fistula devices market by end use key takeaways, (USD Million)
  • Fig. 19 U.S. arteriovenous fistula devices market: by end use movement analysis
  • Fig. 20 Hospitals market, 2021 - 2033 (USD Million)
  • Fig. 21 Ambulatory surgical centers market, 2021 - 2033 (USD Million)
  • Fig. 22 Dialysis centers market, 2021 - 2033 (USD Million)